CCNJ - cyclin J Gene
Also Known as bA690P14.1
Species: Homo sapiens
About CCNJ
This gene has 3 transcripts (splice variants), 235 orthologues and 18 paralogues. Ubiquitous expression in bone marrow (RPKM 3.4), testis (RPKM 2.6) and 25 other tissues.
Summary
Predicted to enable cyclin-dependent protein serine/threonine kinase regulator activity. Predicted to be involved in mitotic cell cycle phase transition and regulation of cyclin-dependent protein serine/threonine kinase activity. Predicted to be part of cyclin-dependent protein kinase holoenzyme complex. Predicted to be active in centrosome; cytoplasm; and nucleus. [provided by Alliance of Genome Resources, Apr 2022]
CCNJ Products (3)
| mRNA | Protein | Name |
|---|---|---|
| NM_001134375.2 | NP_001127847.1 | cyclin-J isoform 1 |
| NM_001134376.2 | NP_001127848.1 | cyclin-J isoform 3 |
| NM_019084.5 | NP_061957.2 | cyclin-J isoform 2 |
CCNJ Protein Structure
Cyclin_N: Cyclin, N-terminal domain (18 - 143)
Cyclin_C: Cyclin, C-terminal domain (145 - 249)
- 0
- 100
- 200
- 300
- 372 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
cyclin-J |
|
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Bladder Transitional Cell Papilloma |
|
|
| Bladder Papillary Transitional Cell Neoplasm |
|
|
| Urinary Tract Papillary Transitional Cell Benign Neoplasm |
|
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS02134 | CCNJ Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service